Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
NCT00264901 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 5652
Last updated 2017-01-31
Summary
This trial is conducted in the United States of America (USA). This trial aims for a comparison of the safety and efficacy in subjects with type 2 diabetes using either self titration or physician guided titration according to the local standard of care.
Conditions
- Diabetes
- Diabetes Mellitus, Type 2
Interventions
- DRUG
-
insulin detemir
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-10-31
- Primary Completion
- 2006-11-30
- Completion
- 2006-11-30
Countries
- United States
Study Locations
More Related Trials
-
Observational Study on Safety of Self-titration of Once Daily Levemir®
NCT00740519 ·Status: COMPLETED
-
Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®
NCT00806897 ·Status: COMPLETED
-
Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes
NCT01542463 ·Status: COMPLETED
-
Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes
NCT00687063 ·Status: COMPLETED
-
Observational Study to Evaluate the Safety of Levemir® in Diabetes
NCT00659295 ·Status: COMPLETED
-
Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes
NCT00700830 ·Status: COMPLETED
-
Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes
NCT00735501 ·Status: COMPLETED
-
An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes
NCT00738153 ·Status: COMPLETED
-
Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes
NCT01545791 ·Status: COMPLETED
-
Efficacy and Safety of Levemir® Used as Basal Insulin
NCT01548248 ·Status: COMPLETED
-
Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics
NCT00697450 ·Status: COMPLETED
-
Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.
NCT00793273 ·Status: COMPLETED
-
Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus
NCT00687284 ·Status: COMPLETED
-
Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes
NCT00506662 ·Status: TERMINATED ·Phase: PHASE4
-
Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes
NCT00104182 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
NCT02298192 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily
NCT00634842 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication
NCT00869908 ·Status: COMPLETED
-
Lantus Versus Levemir Treat-To-Target
NCT00405418 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus
NCT00709475 ·Status: COMPLETED
-
Observational Study to Evaluate the Safety While Using Levemir®
NCT00701155 ·Status: COMPLETED
-
Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin Treatment
NCT00865397 ·Status: COMPLETED
-
A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs)
NCT01868542 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes
NCT00283751 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in Germany
NCT00665808 ·Status: COMPLETED